phenylephrine oral OTC
Selected indexed studies
- Why Is Oral Phenylephrine on the Market After Compelling Evidence of Its Ineffectiveness as a Decongestant? (Ann Pharmacother, 2022) [PMID:35337187]
- Acute ischemic colitis associated with oral decongestant use: a systematic review. (J Clin Transl Res, 2023) [PMID:37275581]
- Acute ischaemic colitis associated with oral phenylephrine decongestant use. (BMJ Case Rep, 2014) [PMID:24895387]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Nonprescription medications for respiratory symptoms: Facts and marketing fictions. (2018) pubmed
- Why Is Oral Phenylephrine on the Market After Compelling Evidence of Its Ineffectiveness as a Decongestant? (2022) pubmed
- Acute ischemic colitis associated with oral decongestant use: a systematic review. (2023) pubmed
- Acute ischaemic colitis associated with oral phenylephrine decongestant use. (2014) pubmed
- Tissue Biocompatibility and Antimicrobial Properties of Sympathomimetic Nasal Solutions for Potential Use in Dental Pulpal Management. (2025) pubmed
- Cardiovascular and Cerebrovascular Events Linked to Abuse and Misuse of Sympathomimetic Nasal Decongestants: A Narrative Review of Clinical Evidence. (2026) pubmed
- Cold, cough, allergy, bronchodilator, and antiasthmatic drug products for over-the-counter human use; amendment of monograph for OTC nasal decongestant drug products. Final rule. (2006) pubmed